Vidicizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vidicizumab, covering 2023-05-17 to 2023-05-17. Get the full timeline:
Most recent: Clinical Trial Update: The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression [Phase 4]